ANI PHARMACEUTICALS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$72.00
-1.59%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-1.3%
3 months
-10.1%
6 months
-10.4%
1 year
-21.7%
Year to date
-8.8%
52-week range
$70.16 – $94.48
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.65B
P/E
15.3
P/B
2.8
P/S
1.7
Revenue
$978.38M
Net income
$108.31M
Diluted EPS
4.63
Gross margin
60.40%
Net margin
11.00%
Return on equity
19.60%
Total debt
$610.49M
Cash
$360.25M
Free cash flow
$172.99M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $266.04M | $24.71M | 62.40% | 9.30% | $53.62M |
| Mar 31, 2026 | $237.46M | $29.49M | 60.60% | 12.40% | $52.3M |
| Dec 31, 2025 | $247.06M | $27.49M | 59.40% | 11.10% | $29.12M |
| Sep 30, 2025 | $227.81M | $26.62M | 59.00% | 11.50% | $37.95M |
| Jun 30, 2025 | $211.37M | $8.55M | 64.70% | 3.90% | $71.8M |
| Mar 31, 2025 | $197.12M | $15.68M | 62.90% | 7.70% | $32.52M |
| Dec 31, 2024 | $190.57M | -$10.28M | 57.90% | -5.60% | $13.47M |
| Sep 30, 2024 | $148.33M | -$24.17M | 57.50% | -16.60% | $7.66M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ANIP news
All market newsNo ticker-linked stories are in the current archive.